Pharma and life sciences accounted for 21% of UK healthcare M&A in 2025, down from 27% a year earlier, as inbound activity ...

LONDON Jan 22 (Reuters) - The British government should offer tax incentives for the pharmaceutical industry to invest in biotechnology, a report produced under the umbrella of the UK's BioIndustry ...

New Flagship Pioneering biotech Quotient Therapeutics has lots to be thankful for this year, namely $50 million in cash, a new U.K. outpost to work from and a formal unveiling as the holiday season ...

Josh is the Global Real Estate transaction lead for GSK, focusing on aligning real estate strategies with business objectives and transforming the portfolio to create the World’s healthiest workplaces ...

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific innovation.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth- -Reiterating financial guidance of approximately $20 million ...

U.K. biotech companies raised 46% less in the third quarter (Q3) of 2025 than in the previous quarter, at £187 million (US$249.3 million). The Q3 2025 figure was also in the shade compared to Q1 2025, ...

It’s been a rough month for several clinical amyotrophic lateral sclerosis (ALS) candidates, but that’s not stopping Eli Lilly from pursuing new drugs of its own for the devastating neurological ...

The analysis by property advisory firm Knight Frank found a 22% increase in the number of life sciences companies domiciled in the UK between 2019 and the end of 2025, to a total of 15,436.